Clinical trial
MIRT and Rotigotine in the Early Stage of PD (MIRT-RT)
To test whether a multidisciplinary intensive rehabilitation treatment (MIRT) slowed down the progression of the disease in Parkinson's disease (PD) "de novo" patients, all treated with Rotigotine, in a randomized controlled study with a 18 months follow-up.
Category | Value |
---|---|
Study start date | 2014-03-24 |